GBCS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GBCS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Selectis Health's revenue per share for the three months ended in Sep. 2024 was $3.27. Selectis Health's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was $12.50.
Warning Sign:
Selectis Health Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Selectis Health was 4.90% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 22.30% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 57.60% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 25.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Selectis Health's Revenue per Share or its related term are showing as below:
During the past 13 years, Selectis Health's highest 3-Year average Revenue Per Share Growth Rate was 95.30% per year. The lowest was -53.60% per year. And the median was -7.60% per year.
The historical data trend for Selectis Health's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Revenue per Share | Get a 7-Day Free Trial | 2.54 | 6.29 | 10.03 | 12.22 | 11.51 |
Selectis Health Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Revenue per Share | Get a 7-Day Free Trial | 2.96 | 3.01 | 3.10 | 3.13 | 3.27 |
For the Medical Care Facilities subindustry, Selectis Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Selectis Health's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Selectis Health's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue Per Share (A: Dec. 2023 ) | = | Revenue (A: Dec. 2023 ) | / | Shares Outstanding (Diluted Average) (A: Dec. 2023 ) |
= | 35.172 | / | 3.055 | |
= | 11.51 |
Selectis Health's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as
Revenue Per Share (Q: Sep. 2024 ) | = | Revenue (Q: Sep. 2024 ) | / | Shares Outstanding (Diluted Average) (Q: Sep. 2024 ) |
= | 10.016 | / | 3.067 | |
= | 3.27 |
Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (OTCPK:GBCS) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Thank you for viewing the detailed overview of Selectis Health's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Lance Baller | director | 10173 BRIARGROVE WAY, HIGHLANDS RANCH CO 80126 |
David J. Furstenberg | director | 1226 WIND CHIME DR., WATERFORD MI 48327 |
Brandon Thall | officer: CFO | 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111 |
Christopher R. Barker | officer: President and COO | 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111 |
Neuman Clifford L Esq | director, 10 percent owner | 6800 NORTH 79TH STREET, SUITE # 200, NIWOT CO 80503 |
Downs John H Jr | director | PO BOX 723040, ATLANTA GA 30339 |
Andrew L Sink | director | P O BOX 531124, BIRMINGHAM AL 35253 |
Joshua Mandell | director | C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 4900, GREENWOOD VILLAGE CO 80111 |
Adam Desmond | director | PO BOX 2036, CARBONDALE CO 81623 |
Jacob Taylor | officer: Secretary | 6800 N. 79TH ST., STE. 200, NIWOT CO 80503 |
Sandra Lee Kuwica | officer: Vice President of Finance | C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 3600, GREENWOOD VILLAGE CO 80111 |
Steven Mark Bathgate | director | 5350 S ROSLYN, SUITE 380, ENGLEWOOD CO 80111 |
Philip S Scarborough | officer: Chief Financial Officer | 595 ATLANTA STREET, SUITE D, ROSWELL GA 30075 |
Christopher F Brogdon | director, officer: President | 2 BUCKHEAD PLAZA, 3050 PEACHTREE ROAD, SUITE 570, ATLANTA GA 30305 |
Brogdon Connie B | other: spouse of Director/President | 6000 LAKE FORREST DR, STE 200, ATLANTA GA 30328 |
From GuruFocus
By Marketwired Marketwired • 11-01-2018
By Don Li2 Don Li2 • 11-12-2021
By Value_Insider Value_Insider • 11-09-2022
By GuruFocus Research • 02-13-2024
By GuruFocus Research • 02-13-2024
By GuruFocusNews GuruFocusNews • 01-11-2022
By Marketwired • 06-21-2024
By Marketwired Marketwired • 05-20-2021
By PurpleRose PurpleRose • 07-11-2022
By Marketwired Marketwired • 05-20-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.